Near future
Contact us
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • Energy
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
August 13 2022

Coronavirus / Russia-Ukraine

Near future

News to understand, anticipate, improve the future.

No Result
View All Result

News to understand, anticipate, improve the future.

Read in:  Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Coronavirus, the USA sends the experimental drug Remdesivir to China

Gilead Sciences gives the Chinese Remdesivir, an experimental drug (still not authorized in humans) used on the first American patient.

Gianluca Ricciodi Gianluca Riccio
in Medicine
Share319Pin31Tweet87SendShare24ShareShare17
Coronavirus, the USA sends the experimental drug Remdesivir to China
February 2 2020
⚪ Reads in 4 minutes
A A

A US biotechnology companyGilead Sciences has formalized an agreement with China to conduct clinical trials on Remdesivir.

Gilead Sciences said Friday that he had provided doses of Remdesivir. It is an experimental antiviral drug. The company delivered doses to doctors for the emergency treatment of a small number of patients infected with the new coronavirus.

Gilead, a company based in Foster City, California, has also formalized an agreement with the Chinese authorities to conduct a clinical trial of the Remdesivir drug in patients with coronavirus infection.


More news about the Coronavirus

Coronavirus Wuhan, BlueDot's AI "saw" the epidemic in advance

The article continues after the related links

Far-UVC works in real scenarios: goodbye infections even indoors

Worldwide outbreak of acute childhood hepatitis: WHO investigates an Adenovirus

Almawave, wearable artificial intelligence that monitors COVID patients

Shanghai, now it's a nightmare: Omicron returns with interests (and a message)

Coronavirus vaccine: in 2003 in 20 months, today in 3 months

Coronavirus, heavier estimates arrive on the number of infections


Health authorities seek treatment for Chinese coronavirus infections. There are currently no specific drugs or vaccines for prevention or cure. Several drug manufacturers have said they are working on developing a vaccine, which could still prevent, but not cure, infections.

The researchers hope to understand whether Gilead's experimental drug Remdesivir and other antivirals can work as treatments.

Remdesivir, experimental drug

It is not authorized for use on humans, but ...

Unlike other antivirals currently under investigation, Gilead's investigational drug is not approved for use in humans. Neither by the American health authorities nor by the international ones.

Sometimes unapproved drugs are used or tested in emergency situations. Those where health authorities believe the drug can help patients who don't have other treatments.

Remdesivir, the experimental treatments

The researchers reported in the New England Journal of Medicine on Friday that they administered the drug to the first American patient found to be infected in Washington state. The man, 35, had traveled to Wuhan, the Chinese city where the outbreak began. After returning to the United States, he was the first person in the country to test positive for the Chinese coronavirus.

The patient was given Remdesivir on the seventh day of his hospitalization, January 26th. The following day his clinical condition improved, and he didn't need a respirator. To date, the patient remains hospitalized, but on the mend. "All the symptoms have resolved except for his cough, which however is decreasing", the researchers wrote.

“The patient had a fever of 39,4 degrees the day we treated him with the Gilead drug. The following day the fever dropped to 37,3 degrees and then progressed normally, " says the doctor George Diaz, patient's attending physician at the Providence Regional Medical Center Everett.

Dr Diaz warned, however, that the drug needs to be studied in large clinical trials to determine if it is an effective treatment for coronavirus.

A spokeswoman for Gilead Sciences declined to say how many patients are receiving the drug or where they are.

In clinical trials of Ebola patients, the drug was less effective than rival treatments. In animal studies, the drug helped reduce lung disease in mice infected with MERS, Middle Eastern respiratory syndrome. It's another coronavirus.

I follow developments, and in case I keep you updated.

tags: CoronavirusGileadredevive
Previous post

Windowless planes will show passengers the world around them

Next Post

A “Trojan” nanoparticle clears the arteries of plaque

COLLABORATE

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff
  • Levitation device lifts building materials

    Levitation device lifts building materials

    5148 Shares
    Share 2059 Tweet 1287
  • Goodbye manual gearbox: the future of the car is marked

    1278 Shares
    Share 511 Tweet 319
  • Sentient or not? It is the least of the problems that AI will give us. Watch out for functions

    1057 Shares
    Share 422 Tweet 264
  • Kubota, the glasses that cure myopia begin retail

    811 Shares
    Share 324 Tweet 203
  • It is the day of CyberOne, the new humanoid robot from Xiaomi

    684 Shares
    Share 274 Tweet 171

archive

Have a look here:

Get back the view with corneal transplant from iPS
Medicine

Get back the view with corneal transplant from iPS

On July 27, the cornea transplant from induced pluripotent cells (iPS), then passed and discharged on August 23. There...

Read More
Elephant in a box, I present the folding sofa that is in a box

Elephant in a box, I present the folding sofa that is in a box

And Google goes on TV

A “living” cement transforms bacteria into replicating bricks

A “living” cement transforms bacteria into replicating bricks

Verge TS, the electric motorcycle that seems to have come out of Tron

Verge TS, the electric motorcycle that seems to have come out of Tron

The daily tomorrow

Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

Subscribe to our newsletter

Environment
Architecture
Artificial intelligence
Gadgets
concepts
Design

Staff
Archives
Advertising
Privacy Policy

Medicine
Spazio
Robotica
Work
Transportation
Energy

To contact the FuturoProssimo editorial team, write to [email protected]

Chinese Version
Édition Française
Deutsche Ausgabe
Japanese version
English Edition
Edição Portuguesa
Русское издание
Spanish edition

This work is distributed under license Creative Commons Attribution 4.0 International.
© 2021 Futuroprossimo

No Result
View All Result
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • Energy
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+